by Katherine Unger Baillie, University of Pennsylvania Credit: University of Pennsylvania Checkpoint inhibitors have become important tools in the cancer-fighting arsenal. By blocking proteins that normally restrain the immune response, these drugs can help the immune system destroy cancer cells. But they don’t work in all patients. And now a new study in Nature Immunology led by...
